AllianceBernstein L.P. 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 7:09 pm Sale | 2023-02-14 | 13G | BioXcel Therapeutics, Inc. BTAI | AllianceBernstein L.P. | 2,471 0.100% | -90,627 (-97.35%) | Filing |
| 2022-02-14 4:02 pm Purchase | 2022-02-14 | 13G | BioXcel Therapeutics, Inc. BTAI | AllianceBernstein L.P. | 93,098 5.400% | 93,098 (New Position) | Filing |